Nuzenio

Psoriasis Trial

Psoriasis Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - StocktwitsStocktwits · Sat, 08 Aug 2026 08:07:36 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 16:04:43 GMTOnce-Daily Pill Zasocitinib Clears Psoriasis at Toughest Sites - AJMCAJMC · Tue, 28 Jul 2026 07:00:00 GMTInnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test - Fierce BiotechFierce Biotech · Mon, 27 Jul 2026 14:08:23 GMTChina's Innocare's psoriasis drug meets main goal in late-stage trial - TradingViewTradingView · Mon, 27 Jul 2026 10:09:30 GMT

Timeline

Sat, 08 Aug 2026 08:07:36 GMTORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits
Fri, 07 Aug 2026 23:10:36 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLive
Fri, 07 Aug 2026 16:04:43 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology Times
Tue, 28 Jul 2026 07:00:00 GMTOnce-Daily Pill Zasocitinib Clears Psoriasis at Toughest Sites - AJMC
Mon, 27 Jul 2026 14:08:23 GMTInnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test - Fierce Biotech
Mon, 27 Jul 2026 10:09:30 GMTChina's Innocare's psoriasis drug meets main goal in late-stage trial - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Psoriasis Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.